Hims & Hers Health, Inc. HIMS
At closeNov 10, 2026, 5:31 PM EST
After hours · Nov 10, 5:31 PM ET
- YTD
- -41.08%
- 1 year
- -53.40%
- Market cap
- 4.46B
- Revenue (ttm)
- 2.87B
- Profit margin
- -6.65%
- EPS (ttm)
- -0.64
- Shares out
- 224.94M
- Forward P/E
- 31.28
- YTD return
- -41.08%
- 1-year return
- -53.40%
- Volume
- 58.43M
- Avg volume
- 11.37M
- Open
- 22.12
- Previous close
- 22.94
- Day's range
- 18.40 – 22.47
- 52-week range
- 13.74 – 41.28
- Analysts
- Hold
- Price target
- 30.69 (+60.4%)
- Earnings date
- Feb 22, 2027
5D -7.58 (-28.46%)
Key statistics
- Enterprise value
- 6.23B
- PEG ratio
- 2.09
- Price / sales
- 1.56
- Price / book
- 12.63
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 48.60%
- Free cash flow
- 525.18M
- Total cash
- 712.22M
- Total debt
- 1.56B
- Return on equity
- -40.77%
- Short % of float
- 27.55%
- 50-day average
- 28.31
- 200-day average
- 26.87
Analyst view
Consensus: hold
- Target (low)
- 23.00
- Target (mean)
- 30.69
- Target (high)
- 42.00
- Strong buy2
- Buy1
- Hold12
- Sell0
- Strong sell0
Next earnings
Feb 22, 2027
Expected Feb 22, 2027. Consensus EPS estimate 0.20144.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 22, 2027 | Dec 30, 2026 | 0.08 | — | — | — |
| Nov 9, 2026 | Sep 30, 2026 | 0.05663 | -0.14 | -0.20 | -347.22% |
| Aug 10, 2026 | Jun 30, 2026 | -0.04979 | -0.37 | -0.32 | -643.12% |
| May 11, 2026 | Mar 31, 2026 | 0.02537 | -0.40 | -0.43 | -1,676.67% |
| Feb 23, 2026 | Dec 31, 2025 | 0.02 | 0.07 | +0.05 | +250.00% |
| Nov 3, 2025 | Sep 30, 2025 | 0.09 | 0.06 | -0.03 | -33.33% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 10, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Nov 10, 2026 | Evercore ISI Group | main | In-Line | In-Line |
| Nov 10, 2026 | Needham | main | Buy | Buy |
| Aug 24, 2026 | Truist Securities | main | Hold | Hold |
| Aug 21, 2026 | Barclays | main | Overweight | Overweight |
| Aug 11, 2026 | Citigroup | main | Neutral | Neutral |
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- hims.com
News
Five States Join FTC Lawsuit Alleging Hims and Hers Engaged in Deceptive and Unlawful Privacy Practices 
Jefferies Maintains Hold on Hims & Hers Health, Lowers Price Target to $24 
HIMS Q3 Earnings Call Highlights Marketing Reset and Margin Pressure 
Weight-Loss Reset Dents Hims & Hers Outlook, But Analyst Sees Opportunity 
Weight-Loss Reset Dents Hims & Hers Outlook, But Analyst Sees Opportunity 
Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steady 
Hims & Hers Celebrated Its Eli Lilly Deal, Then Lost a Quarter of Its Value in a Week 
Morgan Stanley Maintains Equal-Weight on Hims & Hers Health, Lowers Price Target to $25 
HIMS Earnings Stumble on Double Miss, Guidance Becomes New Focus 
These Analysts Revise Their Forecasts On Hims & Hers Health After Q3 Results
Your note
Sign in to keep a note on HIMS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAIRD MELISSA | Chief Operating Officer | Conversion of Exercise of derivative security | May 11, 2025 | 805,083 |
| BOUGHTON SOLEIL | Officer | Sale | Oct 27, 2026 | 293,886 |
| CARROLL PATRICK HARRISON | Officer | Conversion of Exercise of derivative security | Aug 13, 2026 | 197,847 |
| CHI MICHAEL Y | Chief Operating Officer | Sale | Sep 14, 2026 | 456,660 |
| DUDUM ANDREW | Chief Executive Officer | Stock Gift | Aug 24, 2026 | 0 |
| ELSHENAWY MOHAMED | Chief Technology Officer | Sale | Sep 14, 2026 | 185,556 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 12.76% | 28,703,514 | 549.65M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.69% | 10,559,314 | 202.20M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.24% | 9,541,384 | 182.71M | Jun 29, 2026 |
| State Street Corporation | 3.62% | 8,145,699 | 155.98M | Jun 29, 2026 |
| Morgan Stanley | 3.18% | 7,152,498 | 136.97M | Jun 29, 2026 |
| Divisadero Street Capital Management, LP | 2.67% | 6,009,505 | 115.08M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.35% | 7,532,634 | 144.24M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.99% | 6,715,813 | 128.60M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.48% | 5,580,591 | 106.86M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.16% | 4,861,892 | 93.10M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.25% | 2,801,108 | 53.64M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.08% | 2,434,622 | 46.62M | Jun 29, 2026 |